Gelesis Holdings Inc (GLS) Stock
GLS is no longer traded. Gelesis Holdings was delisted from the NYSE in May 2023.
Prices on this page are historical; the last trade was May 10, 2023 at $0.01.
Gelesis Holdings stock price history
GLS final trading statistics
- Final close
- $0.01
- Final trading day
- May 10, 2023
- Market cap at delisting
- $11.63M
- Shares outstanding
- 73.33M
- Final 52-week range
- $0.01 – $5.18
- Avg. volume (final 3 mo.)
- 523,386
- All-time high (split-adj.)
- $10.78 · Feb 2021
- All-time low (split-adj.)
- $0.01 · May 2023
- Return since IPO
- -99.9%
- Beta
- 0.99
- Book value / share
- -$0.34
- Price / book
- -0.04
Gelesis Holdings annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $25.77M | -$55.8M | -$1.31 |
| FY2021 | $11.19M | -$93.3M | -$0.69 |
| FY2020 | $21.44M | -$15.3M | -$0.44 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Gelesis Holdings Inc
Gelesis Holdings, Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. It also offers PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, the company develops GS200 for weight loss in prediabetes and type 2 diabetes; and GS500 for functional constipation. Further, it develops pre-clinical product GS300 for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. Gelesis Holdings, Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Gelesis Holdings stock FAQ
What happened to Gelesis Holdings stock?
Gelesis Holdings stock was delisted from the NYSE. Its final close was $0.01 on May 10, 2023.
Is GLS stock still trading?
No. GLS was delisted from the NYSE in May 2023 and no longer trades on a U.S. exchange.
What was the last price of GLS stock?
GLS closed at $0.01 on its final trading day, May 10, 2023, for a market value of about $11.63M.
What were Gelesis Holdings's revenue and earnings in its last full fiscal year?
Gelesis Holdings reported revenue of $25.77M and net income of -$55.8M in fiscal 2022, its last full year as a public company.
When did Gelesis Holdings go public?
Gelesis Holdings Inc stock began trading on January 13, 2022.